RARE - Company ID 0001515673
As of 2026-09-09, Ultragenyx Pharmaceutical Inc. (RARE) has a market capitalization of $1.47 B, making it the #2359 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-09 | $1.47 B |
| 2026-09-08 | $1.47 B |
| 2026-09-07 | $1.51 B |
| 2026-09-06 | $1.51 B |
| 2026-09-05 | $1.51 B |
| 2026-09-04 | $1.51 B |
| 2026-09-03 | $1.46 B |
| 2026-09-02 | $2.61 B |
| 2026-09-01 | $2.53 B |
| 2026-08-31 | $2.48 B |
| 2026-08-30 | $2.52 B |
| 2026-08-29 | $2.52 B |
As of 2026-09-09, Ultragenyx Pharmaceutical Inc. (RARE) has a market capitalization of $1.47 B, making it the #2359 most valuable US-listed company.
Ultragenyx Pharmaceutical Inc. is the #2359 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-28 | $2.52 B |
| 2026-08-27 | $2.59 B |
| 2026-08-26 | $2.58 B |
| 2026-08-25 | $2.61 B |
| 2026-08-24 | $2.53 B |
| 2026-08-23 | $2.54 B |
| 2026-08-22 | $2.54 B |
| 2026-08-21 | $2.54 B |
| 2026-08-20 | $2.50 B |
| 2026-08-19 | $2.58 B |
| 2026-08-18 | $2.51 B |
| 2026-08-17 | $2.57 B |
| 2026-08-16 | $2.61 B |
| 2026-08-15 | $2.61 B |
| 2026-08-14 | $2.61 B |
| 2026-08-13 | $2.61 B |
| 2026-08-12 | $2.65 B |
| 2026-08-11 | $2.62 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.